ALNY
ALNY
NASDAQ · Biotechnology

Alnylam Pharmaceuticals Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$301.03
+7.51 (+2.56%)
As of Jun 30, 9:36 PM ET ·
Analyst Consensus
Strong Buy
37
Analysts
Very High
Coverage
Buy 28 76%
Hold 9 24%
Sell 0 0%
Price Target
Analyst Price Target -66.0% upside
Low Target $75.08
Average Target $102.31
High Target $108.98
Current Price $301.03
Current
$301.03
Target
$102.31
$75.08 $102.31 avg $108.98
Scenario Analysis
Bear Case
$75.08
-75.1%
Low target
Base Case
$102.31
-66.0%
Avg target
Bull Case
$108.98
+-63.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$495.55
-39.3% from high
52-Week Low
$273.11
+10.2% from low
50-Day SMA
$371.56
-19.0% vs SMA
200-Day SMA
$388.35
-22.5% vs SMA
RSI (14)
46.4
Neutral
Target vs 52W High
$102.31
-79.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%